Why Did LifeVantage (LFVN) Stock Jump 27% After Hours?

Benzinga Earnings
05/27

LifeVantage Corporation (NASDAQ:LFVN) shares surged 27.01% to $8.80 in after-hours trading on Tuesday.

The gain in the stock of the health and wellness company in the late trading session follows an intraday increase of 23.53%, closing the regular session at $6.93, according to Benzinga Pro data.

No immediate catalyst can be known behind the stock move.

What You Should Know

On May 6, LifeVantage announced an 11% quarterly dividend increase, a cash dividend of $0.050 per share of common stock, which will be paid Jun. 15 to all stockholders of record at the close of business on Jun. 1.

The company reported fiscal third-quarter 2026 earnings per share of $0.11, missing analyst estimates of $0.16 by 31.25%. Revenue came in at $43.72 million, falling short of the $47.78 million consensus estimate by 8.51%.

Notably, LFVN carries a short interest of 38.6%, suggesting a significant portion of the move could be short-seller driven.

Trading Metrics, Technical Analysis

LifeVantage has a market capitalization of $87.43 million, with a 52-week high of $15 and a 52-week low of $3.90.

The stock of the Utah-based company has a Relative Strength Index (RSI) of 74.32.

Over the past 12 months, LFVN has dropped 48.17%, but is up 14.93% year to date.

Currently, the small-cap stock is positioned at approximately 27.3% of its 52-week range, closer to the lower end between its yearly low and high.

LFVN's decline and weak positioning suggest continued pressure on the stock, highlighting elevated risk and the need for clearer signs of recovery before investor confidence can improve.

With a strong Value score of 91.51, Benzinga's Edge Stock Rankings suggest that LFVN is in a phase of long-term consolidation while also showing medium and short-term upward momentum.

Photo Courtesy: Champ008 on Shutterstock.com

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Read Also: Soligenix (SNGX) Stock Soars 72% On ThermoVax Platform Promise Amid Ebola Outbreak Caused By Bundibugyo Virus

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10